WORK

WONDERS

 

Resources

Technology

Capital

Miracle Light Venture

BGI's venture capital fund started investing at the end of 2017, focusing on early projects in the field of genes and life science and technology. The fund management team relies on BGI's solid scientific research foundation and industry incubation experience, and relies on the team's professional and prudent industry research and technology assessment. Invested in a number of outstanding start-ups including JunHui Biotech, Neurophth, YuBio, Genewell, Create&Care, etc. As a cutting-edge force that has been established for a short time, Miracle Light Fund will continue to cultivate the industry and become a leading venture capital fund manager in the field of life science and technology with a forward-looking perspective.

Focus on Early Project Investment in Life Science

 

Partners

Cooperation Agency
Investment Institution
Cooperative Media

Service

Activities

Miracle Light Life Science Accelerator, initiated by BGI Group, is a platform of innovation, acceleration and investment in the field of life science and precision medicine, focusing on the frontier research and technologies in DNA, RNA, protein, cell, tissue and other integrative omics, committed to  build innovation ecosystem with all-around support and enhance tech transfer efficacy.

BGI's Innovative Business and Technology Export

The bridge Connecting BGI and External Resources